Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity-Reference-Cited by-同舟云学术

Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity

Published:2013 Issue:1 Volume:5 Page:12
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alzheimers Res Ther

Author:

Ferris Steven,Cummings Jeffrey,Christensen Daniel,Doody Rachelle,Farlow Martin,Sabbagh Marwan,Liu Liang,Mackell Joan,Fain Randi

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Reference12 articles.

1. Alzheimer Disease in the US Population

2. Memantine in Moderate-to-Severe Alzheimer's Disease

3. Cognition, Function, and Caregiving Time Patterns in Patients With Mild-to-Moderate Alzheimer Disease

4. Alzheimer's Disease Assessment Scale: The Validation of the Scale in Greece in Elderly Demented Patients and Normal Subjects

5. Severe Impairment Battery

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-dementia drugs: what is the evidence in advanced stages?;Porto Biomedical Journal;2024-03

2. Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer’s disease: a systematic review and meta-analysis;Expert Opinion on Drug Safety;2022-01-31

3. Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer’s Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial;Dementia and Geriatric Cognitive Disorders;2021

4. Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial;Alzheimer's Research & Therapy;2019-05-01

5. A review of clinical treatment considerations of donepezil in severe Alzheimer's disease;CNS Neuroscience & Therapeutics;2018-07-29